{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T06:23:39Z","timestamp":1776493419688,"version":"3.51.2"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.25127","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T18:33:41Z","timestamp":1605724421000},"page":"e2025127","source":"Crossref","is-referenced-by-count":19,"title":["Association of Race\/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report"],"prefix":"10.1001","volume":"3","author":[{"given":"Calvin L.","family":"Colvin","sequence":"first","affiliation":[{"name":"Department of Epidemiology, University of Alabama at Birmingham, Birmingham"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan B.","family":"King","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City"},{"name":"Institute for Health Research, Kaiser Permanente Colorado, Aurora"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Oparil","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular, Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Jackson T.","family":"Wright","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gbenga","family":"Ogedegbe","sequence":"additional","affiliation":[{"name":"New York University Grossman School of Medicine, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April","family":"Mohanty","sequence":"additional","affiliation":[{"name":"IDEAS Center of Innovation, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah"},{"name":"Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shakia T.","family":"Hardy","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Alabama at Birmingham, Birmingham"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Alabama at Birmingham, Birmingham"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Hess","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City"},{"name":"Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Muntner","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Alabama at Birmingham, Birmingham"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Bress","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2020,11,18]]},"reference":[{"issue":"5","key":"zoi200821r1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"19","key":"zoi200821r2","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"issue":"23","key":"zoi200821r3","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).","volume":"288","author":"Officers","year":"2002","journal-title":"JAMA"},{"issue":"3","key":"zoi200821r4","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1161\/01.HYP.0000231662.77359.de","article-title":"Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.","volume":"48","author":"Leenen","year":"2006","journal-title":"Hypertension"},{"issue":"9311","key":"zoi200821r5","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint Reduction in Hypertension Study (LIFE): a randomised trial against atenolol.","volume":"359","author":"Dahl\u00f6f","year":"2002","journal-title":"Lancet"},{"issue":"19","key":"zoi200821r6","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"zoi200821r8","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data.","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"8","key":"zoi200821r9","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1001\/archinte.1990.00040031707020","article-title":"A comparison of the efficacy and safety of a \u00df-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks.","volume":"150","author":"Saunders","year":"1990","journal-title":"Arch Intern Med"},{"issue":"6","key":"zoi200821r10","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/archinte.160.6.825","article-title":"Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States.","volume":"160","author":"Cushman","year":"2000","journal-title":"Arch Intern Med"},{"issue":"17","key":"zoi200821r11","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1161\/CIRCULATIONAHA.112.096156","article-title":"Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010.","volume":"126","author":"Gu","year":"2012","journal-title":"Circulation"},{"issue":"4","key":"zoi200821r12","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1161\/HYPERTENSIONAHA.119.14360","article-title":"Trends in antihypertensive medication monotherapy and combination use among US adults, National Health and Nutrition Examination Survey 2005-2016.","volume":"75","author":"Derington","year":"2020","journal-title":"Hypertension"},{"issue":"1","key":"zoi200821r13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.7326\/0003-4819-148-1-200801010-00189","article-title":"Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension.","volume":"148","author":"Matchar","year":"2008","journal-title":"Ann Intern Med"},{"issue":"13","key":"zoi200821r14","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.jacc.2018.01.058","article-title":"Angiotensin-converting enzyme inhibitors in hypertension: to use or not to use?","volume":"71","author":"Messerli","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"zoi200821r15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0009-9236(96)90161-7","article-title":"Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema.","volume":"60","author":"Brown","year":"1996","journal-title":"Clin Pharmacol Ther"},{"issue":"14","key":"zoi200821r16","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1001\/archinte.165.14.1637","article-title":"Incidence and characteristics of angioedema associated with enalapril.","volume":"165","author":"Kostis","year":"2005","journal-title":"Arch Intern Med"},{"issue":"6","key":"zoi200821r17","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1161\/HYP.0000000000000067","article-title":"Systematic Review for the 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"71","author":"Reboussin","year":"2018","journal-title":"Hypertension"},{"issue":"19","key":"zoi200821r18","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1001\/jama.289.19.2534","article-title":"Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.","volume":"289","author":"Psaty","year":"2003","journal-title":"JAMA"},{"issue":"12","key":"zoi200821r19","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1503\/cmaj.060110","article-title":"Re-examining the efficacy of \u00df-blockers for the treatment of hypertension: a meta-analysis.","volume":"174","author":"Khan","year":"2006","journal-title":"CMAJ"},{"key":"zoi200821r20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1472-6963-14-87","article-title":"Impact of ethnic-specific guidelines for anti-hypertensive prescribing in primary care in England: a longitudinal study.","volume":"14","author":"Barrera","year":"2014","journal-title":"BMC Health Serv Res"},{"issue":"21","key":"zoi200821r21","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1001\/jama.1997.03550210043036","article-title":"Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing?","volume":"278","author":"Siegel","year":"1997","journal-title":"JAMA"},{"issue":"10","key":"zoi200821r22","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1345\/aph.1A451","article-title":"Medicaid prescriber compliance with Joint National Committee VI Hypertension Treatment Guidelines.","volume":"36","author":"Clause","year":"2002","journal-title":"Ann Pharmacother"},{"issue":"15","key":"zoi200821r23","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","article-title":"Why don\u2019t physicians follow clinical practice guidelines? a framework for improvement.","volume":"282","author":"Cabana","year":"1999","journal-title":"JAMA"},{"issue":"3","key":"zoi200821r24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/healthcare4030036","article-title":"Barriers and strategies in guideline implementation\u2014a scoping review.","volume":"4","author":"Fischer","year":"2016","journal-title":"Healthcare (Basel)"},{"issue":"5","key":"zoi200821r25","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1161\/HYPERTENSIONAHA.113.03097","article-title":"End of the Joint National Committee heritage?","volume":"63","author":"O\u2019Brien","year":"2014","journal-title":"Hypertension"},{"issue":"7","key":"zoi200821r26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.7326\/M13-2981","article-title":"Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view.","volume":"160","author":"Wright","year":"2014","journal-title":"Ann Intern Med"},{"issue":"6","key":"zoi200821r27","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1097\/HJH.0b013e3283603f53","article-title":"Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis.","volume":"31","author":"Levi Marpillat","year":"2013","journal-title":"J Hypertens"},{"key":"zoi200821r7","unstructured":"United States Census Bureau. 2010 Census regions and divisions of the United States. Updated August 20, 2018. Accessed August 20, 2020. https:\/\/www.census.gov\/geographies\/reference-maps\/2010\/geo\/2010-census-regions-and-divisions-of-the-united-states.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2773073\/colvin_2020_oi_200821_1605044924.24635.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T18:33:58Z","timestamp":1605724438000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2773073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,18]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.25127","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,18]]}}}